From protocol amendments to participant recruitment and retention, the impact of COVID-19 could be enormous. What can you do to minimize the disruption to your ongoing, or upcoming, clinical trial? Our panel of experts from NYU Langone Medical Center and WCG discuss ways to reduce the impact of this pandemic on your studies to keep them on track.
Most Recent Flipbooks
More Than Good Intentions: Diversity, Equity & Inclusion Requires a Program-Level, Strategic Framework
The Top 5 Benefits of Outsourcing Expert Committee Management to an Independent Provider
The Challenge of Overreporting: A Fresh Perspective from the FDA
In a recent webinar, Steven Beales, Senior VP, Scientific and Regulatory at WCG, facilitated a conversation with FDA leaders, discussing overreporting SUSARs and the impact on patient safety.
Whitepaper - The Power of More Re-Imagining the Traditional Business Model for Oncology Clinical Research
Save the Data. Protect the Patients. Prepare for What Comes Next: Remote Clinical Research Coordinators
Clinical Research Trends & Insights for 2020
16 industry experts share shifts and trends that will inform clinical research in 2020 and beyond.